Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Nature Communications|November 16, 2017
Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneysHui Peng, Qianqian Wang, Tanqi Lou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2011
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patientsJoel D Kopple, Alfred K Cheung, Jens Sandahl Christiansen, et al.
Kidney International|March 13, 2003
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Barry M Brenner, Dick de Zeeuw, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2008
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patientsJoel D Kopple, Alfred K Cheung, Jens Sandahl Christiansen, et al.
Journal of the American Society of Nephrology : JASN|September 29, 2006
Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditionsBiruh T Workeneh, Helbert Rondon-Berrios, Liping Zhang, et al.
Kidney International|February 26, 2019
Notch signaling in bone marrow-derived FSP-1 cells initiates neointima formation in arteriovenous fistulasMing Liang, Qunying Guo, Fengzhang Huang, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 23, 2013
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM)Juan Jesús Carrero, Peter Stenvinkel, Lilian Cuppari, et al.
Endocrinology|November 28, 2007
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profileMark D Deboer, Xinxia Zhu, Peter R Levasseur, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Pageof 12